501361-99-5

Basic information

• Product Name: Oxazole, 2-(4-fluorophenyl)-4-(iodomethyl)-
• CAS NO: 501361-99-5
• Molecular Formula: C10H7FINO
• Molecular Weight: 303.075
• Mol File: 501361-99-5.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: Oxazole, 2-(4-fluorophenyl)-4-(iodomethyl)-(CAS DataBase Reference)
• NIST Chemistry Reference: Oxazole, 2-(4-fluorophenyl)-4-(iodomethyl)-(501361-99-5)
• EPA Substance Registry System: Oxazole, 2-(4-fluorophenyl)-4-(iodomethyl)-(501361-99-5)

Safety Data

• Hazardous Substances Data: 501361-99-5(Hazardous Substances Data)

Upstream product

• 824-75-9 p-fluorobenzamide 
• 534-07-6 1,3-Dichloroacetone 
• 22091-39-0 4-Chloromethyl-2-(4-fluorophenyl)oxazole 

Downstream Products

• 501362-23-8 5-(2-(4-fluorophenyl)oxazol-4-ylmethoxymethyl)-1,3-dioxan-5-ylmethanol 
• 22087-28-1 2-(2-(4-fluorophenyl)oxazol-4-yl)acetonitrile 
• 1314887-15-4 4-(dimethylamino)-2-(2-(4-fluorophenyl)oxazol-4-yl)butanenitrile 
• 1314887-16-5 3-(2-(4-fluorophenyl)oxazol-4-yl)-N₁,N₁-dimethylbutane-1,4-diamine 
• 1314887-18-7 4-(2-(4-fluorophenyl)oxazol-4-yl)-1-methylpiperidine-4-carbonitrile 
• 1016734-82-9 2-(2-(4-fluorophenyl)oxazol-4-yl)ethanamine 
• 885272-89-9 (2-(4-fluorophenyl)oxazol-4-yl)methanamine 
• 755030-72-9 (1R,3S)-4-(3-benzyloxycyclohexyl-1-oxymethyl)-2-(4-fluoro-phenyl)oxazole 

Relevant articles and documents

COMPOUNDS AND METHODS for the inhibition of HDAC

Disclosed are compounds having the formula: wherein X1, X2, X3, R1, R2, R3, R4, Y, A, Z, L and n are as defined herein, and methods of making and using the same.

Diarylcycloalkyl derivatives, processes for their preparation and their use as pharmaceuticals

Diarylcycloalkyl derivatives and their physiologically acceptable salts and physiologically functional derivatives are disclosed. The compounds include those of formula I, in which the radicals are as defined, and their physiologically acceptable salts an

Process for preparing the enantiomeric forms of cis-configured 1,3-cyclohexanediol derivatives

Process for preparing the enantiomeric forms of cis-configured 1,3-cyclohexanediol derivatives A process is described for preparing chiral, nonracemic, cis-configured 1,3-disubstituted cyclohexanols of the formula (I) where the radicals are as defined, by